News & Information | START In The News

August 17th, 2010
San Antonio Business Journal

START officials select Japanese oncologist to serve as visiting scholar

South Texas Accelerated Research Therapeutics (START) has established a visiting scholar program designed to give young international researchers a chance to participate in cutting-edge cancer trials.

Thanks to funding from ThriveWell Cancer Foundation and the Karen Franklin Gastrointestinal Cancer Memorial Fund, START officials have named Japanese medical oncologist Dr. Toshio Shimizu as its first Visiting Scholar. He will work with the staff for a two-year period.

“START is without a doubt, the largest Phase I Drug Development program in the world and is uniquely positioned within the framework of a comprehensive clinical cancer center ­­— The START Center for Cancer Care — as well as a very robust preclinical in vivo facility, which will give these visiting scholars a one-of-a-kind experience,” says Dr. Amita Patnaik, associate director for clinical research with START and director of the fellowship program.

Shimizu graduated from the Kinki University School of Medicine in Osaka, Japan. He was previously assistant professor in the department of medical oncology at Kinki University. His research focus is the development of new anticancer agents.

“This is also a very exciting opportunity for START as it allows us to mentor young investigators who can take their knowledge and expertise back to their respective countries, ultimately strengthening the global effort to accelerate the development of new agents,” Pantaik says. “By imparting our knowledge to international trainees, we believe that we will be able to enrich the knowledge of the international drug development community, and also facilitate collaborations with international investigators.”

ThriveWell Cancer Foundation is a Texas nonprofit organization that provides support for people suffering with cancer and their families. The organization also supports cancer research.

Read more: START officials select Japanese oncologist to serve as visiting scholar - San Antonio Business Journal